Messner & Smith Theme Value Investment Management’s Ionis Pharmaceuticals IONS Stock Holding History

Messner & Smith Theme Value Investment Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-197	Closed	-$5K	–	91
2016 Q2	$5K	Sell	197 -40,117	-100%	-$1.29M	0.01%	75
2016 Q1	$1.63M	Buy	40,314 +19,016	+89%	+$772K	3.22%	12
2015 Q4	$1.32M	Buy	21,298 +4,298	+25%	+$232K	2.11%	19
2015 Q3	$687K	Sell	17,000 -17,330	-50%	-$897K	1.36%	22
2015 Q2	$1.98M	Buy	34,330 +13,383	+64%	+$851K	2.71%	14
2015 Q1	$1.33M	Buy	+20,947	New	+$1.42M	1.9%	21

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Messner & Smith Theme Value Investment Management's IONS Position: Q3 2016 in Review

Messner & Smith Theme Value Investment Management sold out of Ionis Pharmaceuticals (IONS) in Q3 2016, closing a stake of 197 shares — an estimated $5K sold.

Messner & Smith Theme Value Investment Management first reported a position in IONS in Q1 2015 and held it in 6 quarters. The position peaked at $1.98M in Q2 2015. 281 funds tracked by Wall St. Rank hold IONS as of Q3 2016.

Messner & Smith Theme Value Investment Management reported no remaining Ionis Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
Messner & Smith Theme Value Investment Management sold 197 Ionis Pharmaceuticals shares in Q3 2016, an estimated $5K.
Messner & Smith Theme Value Investment Management first reported a position in Ionis Pharmaceuticals in Q1 2015 and held it in 6 quarters.
Messner & Smith Theme Value Investment Management's Ionis Pharmaceuticals position peaked at $1.98M in Q2 2015.
281 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2016.

Based on Messner & Smith Theme Value Investment Management's 13F filing for Q3 2016, filed 10 Nov 2016.